Skip to content

Clinical randomized controlled trial of Growth Hormone for assisted reproductive technology in elderly patients

Clinical randomized controlled trial of Growth Hormone for assisted reproductive technology in elderly patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012094
Enrollment
Unknown
Registered
2017-07-23
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

A:Using Growth Hormone
B:No use of Growth Hormone

Sponsors

Reproductive Medicine Center, Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
38 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Aged 38 to 42 years old; 2. AFC is greater than or equal to 5; 3. The first time of IVF in our hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with diabetes or cancer. 2. Chromosomal abnormalities. 3. Suffer from severe adenomyosis, endometriosis, intrauterine adhesions and other factors that affect the embryo; 4. implantation obviously; 5. Pregnant contraindicated patients.

Design outcomes

Primary

MeasureTime frame
The number of effective embryos;

Secondary

MeasureTime frame
pregnancy rate;Parturition rate;Gn dosage;

Countries

China

Contacts

Public ContactHaixiang Sun

Reproductive Medicine Center, Nanjing Drum Tower Hospital

stevensunz@163.com+86 13851622008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026